A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 165 participants.
Also called NCT02434263
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 165 participants
- Sponsor
- Vascular Innovations Co. Ltd.
- Registry
-
NCT02434263
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Greece, Hong Kong SAR China, Lithuania, New Zealand, Poland, Thailand
- Registry status
- Unknown status
Technical summary
Registry record NCT02434263. Allocation not applicable; no masking; primary purpose treatment. Start 2015-08-13 (actual); primary completion 2022-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- Hydra TAVI
- Lead sponsor
- Vascular Innovations Co. Ltd.
- Collaborator
- MedPass International
Record details
- Record id
cardio:ct-nct02434263- Content hash
fa049d533e8d2684ffad0e580b8e2362c290a6cef574a6c03f2d7ad4ab4a68db